Earnings · Hong Kong stocks

Livzon Pharmaceutical Group Inc Class H (1513) earnings

Livzon Pharmaceutical Group Inc Class H published its quarterly report on 2026-10-23: net profit -23.10% year on year. The stock moved +6.67% in the 3 trading days after the report.

Report
quarterly report
Published
2026-10-23
Net profit YoY
-23.10%
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+9.47%—
3 days+6.67%—
7 days+14.78%—
14 days+18.84%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 4 of 8 reports (average -2.04%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-10-23-23.10%0.40-21.57%+6.67%——
2026-08-21-44.40%0.40-37.50%-18.94%-13.16%-6.14%
2025-10-23-3.70%0.52-13.33%-2.95%-2.07%-0.87%
2025-08-20+16.10%0.72+26.32%+3.38%-3.88%-12.84%
2025-04-23+9.20%0.71+1.43%-2.24%+10.07%+2.22%
2025-03-26+13.20%0.43+17.81%+1.33%+0.57%+0.40%
2024-10-23+8.00%0.54-5.26%-5.46%-5.81%+1.64%
2024-08-22+3.30%0.62+12.73%+1.88%+24.90%+6.12%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: 1513

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.